{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:27:39Z","timestamp":1793388459013,"version":"4.5.0"},"reference-count":236,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-024-01389-6","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T04:02:56Z","timestamp":1721793776000},"page":"1231-1254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Alzheimer\u2019s disease: from early pathogenesis to novel therapeutic approaches"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0198-6863","authenticated-orcid":false,"given":"Santosh Kumar","family":"Prajapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjit","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-8807","authenticated-orcid":false,"given":"Puneet K.","family":"Samaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"1389_CR1","unstructured":"Abdivalievna AN (2022) Features of cognitive disorders. Innovative society: problems, analysis and development prospects, 101\u2013105"},{"key":"1389_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocn.2018.10.034","volume":"59","author":"MH Ahmad","year":"2019","unstructured":"Ahmad MH, Fatima M, Mondal AC (2019) Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease: rational insights for the therapeutic approaches. J Clin Neurosci 59:6\u201311","journal-title":"J Clin Neuroscience: Official J Neurosurgical Soc Australasia"},{"key":"1389_CR3","doi-asserted-by":"publisher","unstructured":"Ap\u00e1tiga-P\u00e9rez R, Soto-Rojas LO, Campa-C\u00f3rdoba BB, Luna-Viramontes NI, Cuevas E, Villanueva-Fierro I, Ontiveros-Torres MA, Bravo-Mu\u00f1oz M, Flores-Rodr\u00edguez P, Garc\u00e9s-Ramirez L, de la Cruz F (2022) Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease. Metab Brain Dis 37(1):39\u201350. https:\/\/doi.org\/10.1007\/s11011-021-00814-4","DOI":"10.1007\/s11011-021-00814-4"},{"key":"1389_CR4","doi-asserted-by":"publisher","unstructured":"Armstrong RA (2019) Risk factors for Alzheimer\u2019s disease. Folia Neuropathol 57:87\u2013105.\u00a0https:\/\/doi.org\/10.5114\/fn.2019.85929","DOI":"10.5114\/fn.2019.85929"},{"key":"1389_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/postgradmedj-2017-135424","volume":"94","author":"BM Arneth","year":"2018","unstructured":"Arneth BM (2018) Gut\u2013brain axis biochemical signalling from the gastrointestinal tract to the central nervous system: gut dysbiosis and altered brain function. Postgrad Med J 94:446\u2013452","journal-title":"Postgrad Med J"},{"key":"1389_CR6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/alz.12253","volume":"17","author":"MT Ashford","year":"2021","unstructured":"Ashford MT, Veitch DP, Neuhaus J, Nosheny RL, Tosun D, Weiner MW (2021) The search for a convenient procedure to detect one of the earliest signs of Alzheimer\u2019s disease: a systematic review of the prediction of brain amyloid status. Alzheimer\u2019s Dement 17:866\u2013887","journal-title":"Alzheimer\u2019s Dement"},{"key":"1389_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s42254-023-00558-3","volume":"5","author":"N Aslam","year":"2023","unstructured":"Aslam N, Zhou H, Urbach EK, Turner MJ, Walsworth RL, Lukin MD, Park H (2023) Quantum sensors for biomedical applications. Nat Reviews Phys 5:157\u2013169","journal-title":"Nat Reviews Phys"},{"key":"1389_CR8","doi-asserted-by":"publisher","unstructured":"Aso E, Palomer E, Juv\u00e9s S, Maldonado R, Mu\u00f1oz FJ, Ferrer I (2012) CB 1 agonist ACEA protects neurons and reduces the cognitive impairment of A\u03b2PP\/PS1 mice. J Alzheimer's Dis 30(2):439\u2013459. https:\/\/doi.org\/10.3233\/JAD-2012-111862","DOI":"10.3233\/JAD-2012-111862"},{"key":"1389_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/YCT.0000000000000286","volume":"32","author":"K Avirame","year":"2016","unstructured":"Avirame K, Stehberg J, Todder D (2016) Benefits of deep transcranial magnetic stimulation in Alzheimer disease: case series. J ECT 32:127\u2013133","journal-title":"J ECT"},{"key":"1389_CR10","doi-asserted-by":"publisher","first-page":"55709","DOI":"10.1039\/C7RA09767K","volume":"7","author":"M Azimzadeh","year":"2017","unstructured":"Azimzadeh M, Nasirizadeh N, Rahaie M, Naderi-Manesh H (2017) Early detection of Alzheimer\u2019s disease using a biosensor based on electrochemically-reduced graphene oxide and gold nanowires for the quantification of serum microRNA-137. RSC Adv 7:55709\u201355719","journal-title":"RSC Adv"},{"key":"1389_CR11","doi-asserted-by":"publisher","first-page":"174310","DOI":"10.1016\/j.ejphar.2021.174310","volume":"908","author":"P Babaei","year":"2021","unstructured":"Babaei P (2021) NMDA and AMPA receptors dysregulation in Alzheimer\u2019s disease. Eur J Pharmacol 908:174310","journal-title":"Eur J Pharmacol"},{"key":"1389_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/jnnp.67.4.558","volume":"67","author":"T Babic","year":"1999","unstructured":"Babic T (1999) The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. J Neurol Neurosurg Psychiatry 67:558","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1389_CR13","doi-asserted-by":"publisher","unstructured":"Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Ch\u00e9telat G ( 2019) Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need. Alzheimer's & Dementia 15(2):292\u2013312. https:\/\/doi.org\/10.1016\/j.jalz.2018.09.009","DOI":"10.1016\/j.jalz.2018.09.009"},{"key":"1389_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/bs.pbr.2014.11.028","volume":"217","author":"A Baird","year":"2015","unstructured":"Baird A, Samson S (2015) Music and dementia. Prog Brain Res 217:207\u2013235","journal-title":"Prog Brain Res"},{"key":"1389_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41380-021-01385-7","volume":"27","author":"P Bakrania","year":"2022","unstructured":"Bakrania P, Hall G, Bouter Y, Bouter C, Beindorff N, Cowan R, Davies S, Price J, Mpamhanga C, Love E (2022) Discovery of a novel pseudo \u03b2-hairpin structure of N-truncated amyloid-\u03b2 for use as a vaccine against Alzheimer\u2019s disease. Mol Psychiatry 27:840\u2013848","journal-title":"Mol Psychiatry"},{"key":"1389_CR16","doi-asserted-by":"publisher","unstructured":"Barage SH, Sonawane KD (2015) Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer's disease. Neuropeptides 52:1\u20138. https:\/\/doi.org\/10.1016\/j.npep.2015.06.008","DOI":"10.1016\/j.npep.2015.06.008"},{"key":"1389_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2022.12625","volume":"25","author":"S Bashir","year":"2022","unstructured":"Bashir S, Uzair M, Abualait T, Arshad M, Khallaf RA, Niaz A, Thani Z, Yoo W-K, T\u00fanez I, Demirtas\u2013Tatlidede A (2022) Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer\u2019s disease. Mol Med Rep 25:1\u201317","journal-title":"Mol Med Rep"},{"key":"1389_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/1097-0029(20000815)50:4<278::AID-JEMT5>3.0.CO;2-T","volume":"50","author":"L Baum","year":"2000","unstructured":"Baum L, Chen L, Ng HK, Pang CP (2000) Apolipoprotein E isoforms in Alzheimer\u2019s disease pathology and etiology. Microsc Res Tech 50:278\u2013281","journal-title":"Microsc Res Tech"},{"key":"1389_CR19","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.neurobiolaging.2005.09.034","volume":"27","author":"KF Bell","year":"2006","unstructured":"Bell KF, Ducatenzeiler A, Ribeiro-da-Silva A, Duff K, Bennett DA, Cuello AC (2006) The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging 27:1644\u20131657","journal-title":"Neurobiol Aging"},{"key":"1389_CR20","doi-asserted-by":"crossref","unstructured":"Ben Khedher MR, Haddad M, Laurin D, Ramassamy C (2021) Effect of APOE \u03b54 allele on levels of apolipoproteins E, J, and D, and redox signature in circulating extracellular vesicles from cognitively impaired with no dementia participants converted to Alzheimer\u2019s disease. Alzheimer\u2019s Dem (Amst) 13:e12231","DOI":"10.1002\/dad2.12231"},{"key":"1389_CR21","doi-asserted-by":"publisher","unstructured":"Bennett RE, DeVos SL, Dujardin S, Corjuc B, Gor R, Gonzalez J, Roe AD, Frosch MP, Pitstick R, Carlson GA, Hyman BT (2017) Enhanced tau aggregation in the presence of amyloid \u03b2. Am J Clin Pathol\u00a0187(7):1601\u20131612. https:\/\/doi.org\/10.1016\/j.ajpath.2017.03.011","DOI":"10.1016\/j.ajpath.2017.03.011"},{"key":"1389_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1474-4422(09)70332-1","volume":"9","author":"BA Bergmans","year":"2010","unstructured":"Bergmans BA, De Strooper B (2010) \u03b3-secretases: from cell biology to therapeutic strategies. Lancet Neurol 9:215\u2013226","journal-title":"Lancet Neurol"},{"key":"1389_CR23","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.3390\/ijms20143606","volume":"20","author":"L Bernardi","year":"2019","unstructured":"Bernardi L, Bruni AC (2019) Mutations in prion protein gene: pathogenic mechanisms in C-terminal vs. N-terminal domain, a review. Int J Mol Sci 20:3606","journal-title":"Int J Mol Sci"},{"key":"1389_CR24","doi-asserted-by":"publisher","first-page":"174361","DOI":"10.1016\/j.ejphar.2021.174361","volume":"908","author":"A Bhattacharjee","year":"2021","unstructured":"Bhattacharjee A, Prajapati SK, Krishnamurthy S (2021) Supplementation of taurine improves ionic homeostasis and mitochondrial function in the rats exhibiting post-traumatic stress disorder-like symptoms. Eur J Pharmacol 908:174361","journal-title":"Eur J Pharmacol"},{"key":"1389_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-015-0186-2","volume":"3","author":"LJ Blair","year":"2015","unstructured":"Blair LJ, Frauen HD, Zhang B, Nordhues BA, Bijan S, Lin Y-C, Zamudio F, Hernandez LD, Sabbagh JJ, Selenica M-LB (2015) Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. Acta Neuropathol Commun 3:1\u201322","journal-title":"Acta Neuropathol Commun"},{"key":"1389_CR26","doi-asserted-by":"publisher","unstructured":"Bortot B, Romani A, Ricci G, Biffi S (2022) Exploiting extracellular vesicles strategies to modulate cell death and inflammation in COVID-19. Front Pharmacol 13:877422.\u00a0https:\/\/doi.org\/10.3389\/fphar.2022.877422","DOI":"10.3389\/fphar.2022.877422"},{"key":"1389_CR27","doi-asserted-by":"publisher","first-page":"120644","DOI":"10.1016\/j.talanta.2019.120644","volume":"210","author":"LC Brazaca","year":"2020","unstructured":"Brazaca LC, Sampaio I, Zucolotto V, Janegitz BC (2020) Applications of biosensors in Alzheimer\u2019s disease diagnosis. Talanta 210:120644","journal-title":"Talanta"},{"key":"1389_CR28","doi-asserted-by":"publisher","unstructured":"Brookes MJ, Leggett J, Rea M, Hill RM, Holmes N, Boto E, Bowtell R (2022) Magnetoencephalography with optically pumped magnetometers (OPM-MEG): the next generation of functional neuroimaging. Trends Neurosci 45:621\u2013634.\u00a0https:\/\/doi.org\/10.1016\/j.tins.2022.05.008","DOI":"10.1016\/j.tins.2022.05.008"},{"key":"1389_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L Bu\u00e9e","year":"2000","unstructured":"Bu\u00e9e L, Bussi\u00e8re T, Bu\u00e9e-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95\u2013130","journal-title":"Brain Res Rev"},{"key":"1389_CR30","doi-asserted-by":"crossref","unstructured":"Cai Z, Qiao PF, Wan CQ, Cai M, Zhou NK, Li Q (2018) Role of blood-brain barrier in alzheimer's disease. J Alzheimers Dis 63:1223\u20131234","DOI":"10.3233\/JAD-180098"},{"key":"1389_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3934\/Neuroscience.2021005","volume":"8","author":"M Calabr\u00f2","year":"2021","unstructured":"Calabr\u00f2 M, Rinaldi C, Santoro G, Crisafulli C (2021) The biological pathways of Alzheimer disease: a review. AIMS Neurosci 8:86","journal-title":"AIMS Neurosci"},{"key":"1389_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3233\/JAD-190331","volume":"70","author":"L Calder\u00f3n-Garcidue\u00f1as","year":"2019","unstructured":"Calder\u00f3n-Garcidue\u00f1as L, Gonz\u00e1lez-Maciel A, Kulesza RJ, Gonz\u00e1lez-Gonz\u00e1lez LO, Reynoso-Robles R, Mukherjee PS, Torres-Jard\u00f3n R (2019) Air pollution, combustion and friction derived nanoparticles, and Alzheimer\u2019s disease in urban children and young adults. J Alzheimers Dis 70:343\u2013360","journal-title":"J Alzheimers Dis"},{"key":"1389_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/jnc.14345","volume":"146","author":"B Calvo-Flores Guzm\u00e1n","year":"2018","unstructured":"Calvo-Flores Guzm\u00e1n B, Vinnakota C, Govindpani K, Waldvogel HJ, Faull RLM, Kwakowsky A (2018) The GABAergic system as a therapeutic target for Alzheimer\u2019s disease. J Neurochem 146:649\u2013669","journal-title":"J Neurochem"},{"key":"1389_CR34","first-page":"1","volume":"7","author":"CE Carro","year":"2019","unstructured":"Carro CE, Pilozzi AR, Huang X (2019) Nanoneurotoxicity and potential nanotheranostics for Alzheimer\u2019s disease. EC Pharmacol Toxicol 7:1","journal-title":"EC Pharmacol Toxicol"},{"key":"1389_CR35","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1582-4934.2007.00130.x","volume":"11","author":"A Cedazo-M\u00ednguez","year":"2007","unstructured":"Cedazo-M\u00ednguez A (2007) Apolipoprotein E and Alzheimer\u2019s disease: molecular mechanisms and therapeutic opportunities. J Cell Mol Med 11:1227\u20131238","journal-title":"J Cell Mol Med"},{"key":"1389_CR36","doi-asserted-by":"publisher","first-page":"fcab029","DOI":"10.1093\/braincomms\/fcab029","volume":"3","author":"K Ceyz\u00e9riat","year":"2021","unstructured":"Ceyz\u00e9riat K, Gloria Y, Tsartsalis S, Fossey C, Cailly T, Fabis F, Millet P, Tournier BB (2021) Alterations in dopamine system and in its connectivity with serotonin in a rat model of Alzheimer\u2019s disease. Brain Commun 3:fcab029","journal-title":"Brain Commun"},{"key":"1389_CR37","doi-asserted-by":"publisher","unstructured":"Chami M (2021) Calcium signalling in Alzheimer\u2019s disease: from pathophysiological regulation to therapeutic approaches. Cells 10:140 https:\/\/doi.org\/10.3390\/cells10010140","DOI":"10.3390\/cells10010140"},{"key":"1389_CR38","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/alz.12447","volume":"18","author":"P Chatterjee","year":"2022","unstructured":"Chatterjee P, Pedrini S, Ashton NJ, Tegg M, Goozee K, Singh AK, Karikari TK, Simr\u00e9n J, Vanmechelen E, Armstrong NJ (2022) Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer\u2019s disease. Alzheimer\u2019s Dement 18:1141\u20131154","journal-title":"Alzheimer\u2019s Dement"},{"key":"1389_CR39","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cmet.2022.02.008","volume":"34","author":"X Chen","year":"2022","unstructured":"Chen X, Calandrelli R, Girardini J, Yan Z, Tan Z, Xu X, Hiniker A, Zhong S (2022) PHGDH expression increases with progression of Alzheimer\u2019s disease pathology and symptoms. Cell Metab 34:651\u2013653","journal-title":"Cell Metab"},{"key":"1389_CR40","doi-asserted-by":"publisher","first-page":"6475","DOI":"10.1038\/s41598-019-42931-2","volume":"9","author":"P Chiozzi","year":"2019","unstructured":"Chiozzi P, Sarti AC, Sanz JM, Giuliani AL, Adinolfi E, Vultaggio-Poma V, Falzoni S, Di Virgilio F (2019) Amyloid \u03b2-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine. Sci Rep 9:6475","journal-title":"Sci Rep"},{"key":"1389_CR41","doi-asserted-by":"publisher","unstructured":"Chou Y-h, Sundmana M, That VT, Greena J, Trapani C (2022) Cortical excitability and plasticity in Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis of transcranial magnetic stimulation studies. Ageing Res Rev 79:101660.\u00a0https:\/\/doi.org\/10.1016\/j.arr.2022.101660","DOI":"10.1016\/j.arr.2022.101660"},{"key":"1389_CR42","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1001\/archneur.63.11.1602","volume":"63","author":"M Cotelli","year":"2006","unstructured":"Cotelli M, Manenti R, Cappa SF, Geroldi C, Zanetti O, Rossini PM, Miniussi C (2006) Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. Arch Neurol 63:1602\u20131604","journal-title":"Arch Neurol"},{"key":"1389_CR43","doi-asserted-by":"crossref","unstructured":"Coyle JT, Price DL, DeLong MR (1983) Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation. Science 219:1184\u20131190","DOI":"10.1126\/science.6338589"},{"key":"1389_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0009-8981(03)00241-9","volume":"334","author":"P D\u2019Orazio","year":"2003","unstructured":"D\u2019Orazio P (2003) Biosensors in clinical chemistry. Clin Chim Acta 334:41\u201369","journal-title":"Clin Chim Acta"},{"key":"1389_CR45","doi-asserted-by":"publisher","first-page":"114050","DOI":"10.1016\/j.jelechem.2020.114050","volume":"872","author":"W da Silva","year":"2020","unstructured":"da Silva W, Brett CM (2020) Novel biosensor for acetylcholine based on acetylcholinesterase\/poly (neutral red)\u2013deep eutectic solvent\/Fe2O3 nanoparticle modified electrode. J Electroanal Chem 872:114050","journal-title":"J Electroanal Chem"},{"key":"1389_CR46","doi-asserted-by":"publisher","first-page":"e21891","DOI":"10.1371\/journal.pone.0021891","volume":"6","author":"JN Dai","year":"2011","unstructured":"Dai JN, Zong Y, Zhong LM, Li YM, Zhang W, Bian LG, Ai QL, Liu YD, Sun J, Lu D (2011) Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS ONE 6:e21891","journal-title":"PLoS ONE"},{"key":"1389_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/bios7010010","volume":"7","author":"Y Dai","year":"2017","unstructured":"Dai Y, Molazemhosseini A, Liu CC (2017) A single-use, in vitro biosensor for the detection of T-tau protein, a biomarker of neuro-degenerative disorders, in PBS and human serum using differential pulse voltammetry (DPV). Biosensors 7:10","journal-title":"Biosensors"},{"key":"1389_CR48","doi-asserted-by":"publisher","unstructured":"Davies SN, Pertwee RG, Riedel G (2002) Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42(8):993\u20131007. https:\/\/doi.org\/10.1016\/s0028-3908(02)00060-6","DOI":"10.1016\/s0028-3908(02)00060-6"},{"key":"1389_CR49","doi-asserted-by":"publisher","unstructured":"De Miguel Z, Khoury N, Betley MJ, Lehallier B, Willoughby D, Olsson N, Yang AC, Hahn O, Lu N, Vest RT, Bonanno LN (2021) Exercise plasma boosts memory and dampens brain inflammation via clusterin. Nature 600(7889):494\u2013499. https:\/\/doi.org\/10.1038\/s41586-021-04183-x","DOI":"10.1038\/s41586-021-04183-x"},{"key":"1389_CR50","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s12031-011-9553-z","volume":"45","author":"L De Muynck","year":"2011","unstructured":"De Muynck L, Van Damme P (2011) Cellular effects of progranulin in health and disease. J Mol Neurosci 45:549\u2013560","journal-title":"J Mol Neurosci"},{"key":"1389_CR51","doi-asserted-by":"publisher","unstructured":"Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH (2021) Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease. Inflammopharmacology 1:1\u20133. https:\/\/doi.org\/10.1007\/s10787-021-00889-6","DOI":"10.1007\/s10787-021-00889-6"},{"key":"1389_CR52","doi-asserted-by":"publisher","unstructured":"Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-Tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D (1996) Increased amyloid-\u03b242 (43) in brains of mice expressing mutant presenilin 1. Nature 383(6602):710\u2013713. https:\/\/doi.org\/10.1038\/383710a0","DOI":"10.1038\/383710a0"},{"key":"1389_CR53","doi-asserted-by":"publisher","unstructured":"Edwin TH, Henjum K, Nilsson LN, Watne LO, Persson K, Eldholm RS, Saltvedt I, Halaas NB, Selb\u00e6k G, Engedal K (2020) A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer\u2019s disease. Alzheimer\u2019s Dement (Amst) 12:e12128 https:\/\/doi.org\/10.1002\/dad2.12128","DOI":"10.1002\/dad2.12128"},{"key":"1389_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0184-x","volume":"12","author":"AG Efthymiou","year":"2017","unstructured":"Efthymiou AG, Goate AM (2017) Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk. Mol Neurodegeneration 12:1\u201312","journal-title":"Mol Neurodegeneration"},{"key":"1389_CR55","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1523\/JNEUROSCI.3498-17.2019","volume":"39","author":"LP Elia","year":"2019","unstructured":"Elia LP, Mason AR, Alijagic A, Finkbeiner S (2019) Genetic regulation of neuronal progranulin reveals a critical role for the autophagy-lysosome pathway. J Neurosci 39:3332\u20133344","journal-title":"J Neurosci"},{"key":"1389_CR56","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s11033-011-0973-1","volume":"39","author":"A-M Enciu","year":"2012","unstructured":"Enciu A-M, Popescu BO, Gheorghisan-Galateanu A (2012) MicroRNAs in brain development and degeneration. Mol Biol Rep 39:2243\u20132252","journal-title":"Mol Biol Rep"},{"key":"1389_CR57","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","volume":"33","author":"MA Erickson","year":"2013","unstructured":"Erickson MA, Banks WA (2013) Blood\u2013brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease. J Cereb Blood Flow Metabolism 33:1500\u20131513","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"1389_CR58","doi-asserted-by":"publisher","first-page":"eaav6221","DOI":"10.1126\/scitranslmed.aav6221","volume":"11","author":"M Ewers","year":"2019","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, Piccio L, Cruchaga C, Deming Y, Dichgans M (2019) Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med 11:eaav6221","journal-title":"Sci Transl Med"},{"key":"1389_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nlm.2016.05.001","volume":"135","author":"A Fiorenza","year":"2016","unstructured":"Fiorenza A, Barco A (2016) Role of Dicer and the miRNA system in neuronal plasticity and brain function. Neurobiol Learn Mem 135:3\u201312","journal-title":"Neurobiol Learn Mem"},{"key":"1389_CR60","doi-asserted-by":"publisher","unstructured":"Fontana IC, Scarpa M, Malarte ML, Rocha FM, Ausell\u00e9-Bosch S, Bluma M, Bucci M, Chiotis K, Kumar A, Nordberg A (2023) Astrocyte signature in Alzheimer\u2019s disease continuum through a Multi-PET tracer imaging perspective. Cells 12:1469 https:\/\/doi.org\/10.3390\/cells12111469","DOI":"10.3390\/cells12111469"},{"key":"1389_CR61","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1523\/JNEUROSCI.0081-05.2005","volume":"25","author":"MS Forman","year":"2005","unstructured":"Forman MS, Lal D, Zhang B, Dabir DV, Swanson E, Lee VM-Y, Trojanowski JQ (2005) Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J Neurosci 25:3539\u20133550","journal-title":"J Neurosci"},{"key":"1389_CR62","doi-asserted-by":"publisher","unstructured":"Fu Y, Yang J, Wang X, Yang P, Zhao Y, Li K, Chen Y, Xu Y (2018) Herbal compounds play a role in neuroprotection through the inhibition of microglial activation. J Immunol Res.\u00a0https:\/\/doi.org\/10.1155\/2018\/9348046","DOI":"10.1155\/2018\/9348046"},{"key":"1389_CR63","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuroscience.2017.03.041","volume":"351","author":"TE Fuhrer","year":"2017","unstructured":"Fuhrer TE, Palpagama TH, Waldvogel HJ, Synek BJL, Turner C, Faull RL, Kwakowsky A (2017) Impaired expression of GABA transporters in the human Alzheimer\u2019s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus. Neuroscience 351:108\u2013118","journal-title":"Neuroscience"},{"key":"1389_CR64","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1017\/S1092852900018976","volume":"8","author":"MS George","year":"2003","unstructured":"George MS, Nahas Z, Kozel FA, Li X, Yamanaka K, Mishory A, Bohning DE (2003) Mechanisms and the current state of transcranial magnetic stimulation. CNS Spectr 8:496\u2013514","journal-title":"CNS Spectr"},{"key":"1389_CR65","doi-asserted-by":"publisher","first-page":"105212","DOI":"10.1016\/j.neuint.2021.105212","volume":"151","author":"P Ghosh","year":"2021","unstructured":"Ghosh P, Singh R, Ganeshpurkar A, Pokle AV, Singh RB, Singh SK, Kumar A (2021) Cellular and molecular influencers of neuroinflammation in Alzheimer\u2019s disease: recent concepts & roles. Neurochem Int 151:105212","journal-title":"Neurochem Int"},{"key":"1389_CR66","doi-asserted-by":"publisher","first-page":"22412","DOI":"10.1038\/s41598-021-01854-7","volume":"11","author":"A Gialopsou","year":"2021","unstructured":"Gialopsou A, Abel C, James TM, Coussens T, Bason MG, Puddy R, Di Lorenzo F, Rolfs K, Voigt J, Sander T (2021) Improved spatio-temporal measurements of visually evoked fields using optically-pumped magnetometers. Sci Rep 11:22412","journal-title":"Sci Rep"},{"key":"1389_CR67","doi-asserted-by":"crossref","unstructured":"Giau VV, Bagyinszky E, Youn YC, An SSA, Kim S (2019) APP, PSEN1, and PSEN2 mutations in Asian patients with early-onset Alzheimer disease. Int J Mol Sci 20:4757","DOI":"10.3390\/ijms20194757"},{"key":"1389_CR68","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/imm.12177","volume":"141","author":"D Giunti","year":"2014","unstructured":"Giunti D, Parodi B, Cordano C, Uccelli A, Kerlero de Rosbo N (2014) Can we switch microglia\u2019s phenotype to foster neuroprotection? Focus on multiple sclerosis. Immunology 141:328\u2013339","journal-title":"Immunology"},{"key":"1389_CR69","doi-asserted-by":"publisher","unstructured":"Gleason A, Bush AI (2021) Iron and ferroptosis as therapeutic targets in Alzheimer's disease. Neurotherapeutics 18(1):252\u2013264. https:\/\/doi.org\/10.1007\/s13311-020-00954-y","DOI":"10.1007\/s13311-020-00954-y"},{"key":"1389_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.conb.2017.11.006","volume":"48","author":"CE Golden","year":"2018","unstructured":"Golden CE, Buxbaum JD, De Rubeis S (2018) Disrupted circuits in mouse models of autism spectrum disorder and intellectual disability. Curr Opin Neurobiol 48:106\u2013112","journal-title":"Curr Opin Neurobiol"},{"key":"1389_CR71","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fnmol.2017.00427","volume":"10","author":"RE Gonz\u00e1lez-Reyes","year":"2017","unstructured":"Gonz\u00e1lez-Reyes RE, Nava-Mesa MO, Vargas-S\u00e1nchez K, Ariza-Salamanca D, Mora-Mu\u00f1oz L (2017) Involvement of astrocytes in Alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective. Front Mol Neurosci 10:427","journal-title":"Front Mol Neurosci"},{"key":"1389_CR72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","volume":"13","author":"M Gratuze","year":"2018","unstructured":"Gratuze M, Leyns CEG, Holtzman DM (2018) New insights into the role of TREM2 in Alzheimer\u2019s disease. Mol Neurodegeneration 13:66","journal-title":"Mol Neurodegeneration"},{"key":"1389_CR73","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3233\/JAD-170343","volume":"60","author":"R Guo","year":"2017","unstructured":"Guo R, Fan G, Zhang J, Wu C, Du Y, Ye H, Li Z, Wang L, Zhang Z, Zhang L (2017) A 9-microRNA signature in serum serves as a noninvasive biomarker in early diagnosis of Alzheimer\u2019s disease. J Alzheimers Dis 60:1365\u20131377","journal-title":"J Alzheimers Dis"},{"issue":"Suppl 2","key":"1389_CR74","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/jnc.14052","volume":"142","author":"J Haam","year":"2017","unstructured":"Haam J, Yakel JL (2017) Cholinergic modulation of the hippocampal region and memory function. J Neurochem 142(Suppl 2):111\u2013121","journal-title":"J Neurochem"},{"key":"1389_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/j.1440-1614.2006.01736.x","volume":"40","author":"MM Haby","year":"2006","unstructured":"Haby MM, Donnelly M, Corry J, Vos T (2006) Cognitive behavioural therapy for depression, panic disorder and generalized anxiety disorder: a meta-regression of factors that may predict outcome. Australian New Z J Psychiatry 40:9\u201319","journal-title":"Aust N Z J Psychiatry"},{"key":"1389_CR76","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ, Khachaturian ZS (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain 141:1917\u20131933","journal-title":"Brain"},{"key":"1389_CR77","first-page":"2","volume":"6","author":"H Hampel","year":"2019","unstructured":"Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Vergallo A, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS (2019) Revisiting the Cholinergic hypothesis in Alzheimer\u2019s Disease: emerging evidence from translational and clinical research. J Prev Alzheimer\u2019s Disease 6:2\u201315","journal-title":"J Prev Alzheimer\u2019s Disease"},{"key":"1389_CR78","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/1565","volume":"1","author":"J Hardy","year":"1998","unstructured":"Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M (1998) Genetic dissection of Alzheimer\u2019s disease and related dementias: amyloid and its relationship to tau. Nat Neurosci 1:355\u2013358","journal-title":"Nat Neurosci"},{"key":"1389_CR79","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.conb.2006.09.002","volume":"16","author":"ME Hasselmo","year":"2006","unstructured":"Hasselmo ME (2006) The role of acetylcholine in learning and memory. Curr Opin Neurobiol 16:710\u2013715","journal-title":"Curr Opin Neurobiol"},{"key":"1389_CR80","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/1073858419882619","volume":"26","author":"D Hefter","year":"2020","unstructured":"Hefter D, Ludewig S, Draguhn A, Korte M (2020) Amyloid, APP, and electrical activity of the brain. Neuroscientist: Rev J Bringing Neurobiol Neurol Psychiatry 26:231\u2013251","journal-title":"Neuroscientist"},{"key":"1389_CR81","doi-asserted-by":"publisher","unstructured":"Hill E, Karikari TK, Moffat KG, Richardson MJ, Wall MJ (2019) Introduction of tau oligomers into cortical neurons alters action potential dynamics and disrupts synaptic transmission and plasticity. eNeuro.\u00a0https:\/\/doi.org\/10.1523\/ENEURO.0166-19.2019","DOI":"10.1523\/ENEURO.0166-19.2019"},{"key":"1389_CR82","doi-asserted-by":"publisher","unstructured":"H\u00f6hn A, Tramutola A, Cascella R (2020) Proteostasis failure in neurodegenerative diseases: focus on oxidative stress.\u00a0Oxid Med Cell Longev.\u00a0https:\/\/doi.org\/10.1155\/2020\/5497046","DOI":"10.1155\/2020\/5497046"},{"key":"1389_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1309-z","volume":"15","author":"SC Hopp","year":"2018","unstructured":"Hopp SC, Lin Y, Oakley D, Roe AD, DeVos SL, Hanlon D, Hyman BT (2018) The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer\u2019s disease. J Neuroinflamm 15:1\u201315","journal-title":"J Neuroinflamm"},{"key":"1389_CR84","doi-asserted-by":"publisher","unstructured":"Hu Z, Crews CM (2022) Recent developments in PROTAC\u2010mediated protein degradation: from bench to clinic. Chem Bio Chem 23(2):e202100270. https:\/\/doi.org\/10.1002\/cbic.202100270","DOI":"10.1002\/cbic.202100270"},{"key":"1389_CR85","doi-asserted-by":"crossref","unstructured":"Hu S, Yang C, Luo H (2022) Current trends in blood biomarker detection and imaging for Alzheimer\u2019s disease.\u00a0Biosens Bioelectron 210:114278","DOI":"10.1016\/j.bios.2022.114278"},{"key":"1389_CR86","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1021\/jacs.2c11706","volume":"145","author":"Z Hu","year":"2023","unstructured":"Hu Z, Chen P-H, Li W, Douglas T, Hines J, Liu Y, Crews CM (2023) Targeted dephosphorylation of tau by phosphorylation targeting chimeras (PhosTACs) as a therapeutic modality. J Am Chem Soc 145:4045\u20134055","journal-title":"J Am Chem Soc"},{"key":"1389_CR87","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3233\/JAD-161186","volume":"57","author":"Y Huang","year":"2017","unstructured":"Huang Y, Shen W, Su J, Cheng B, Li D, Liu G, Zhou WX, Zhang YX (2017) Modulating the balance of synaptic and extrasynaptic NMDA receptors shows positive effects against Amyloid-\u03b2-Induced neurotoxicity. J Alzheimer\u2019s Disease: JAD 57:885\u2013897","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"1389_CR88","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1021\/acs.jproteome.1c00558","volume":"21","author":"EE Hubbard","year":"2022","unstructured":"Hubbard EE, Heil LR, Merrihew GE, Chhatwal JP, Farlow MR, McLean CA, Ghetti B, Newell KL, Frosch MP, Bateman RJ, Larson EB, Keene CD, Perrin RJ, Montine TJ, MacCoss MJ, Julian RR (2022) Does data-independent acquisition data contain hidden gems? A case study related to Alzheimer\u2019s Disease. J Proteome Res 21:118\u2013131","journal-title":"J Proteome Res"},{"key":"1389_CR89","doi-asserted-by":"crossref","unstructured":"Hughes LE, Adams NE, Phillips H, Murley AG, Shaw A, Nesbitt D, Cope TE, Bevan-Jones WR, Passamonti L, Rowe JB (2021) Magnetoencephalography insights to dementia and drug intervention. Alzheimer\u2019s Dement 17:e052536","DOI":"10.1002\/alz.052536"},{"key":"1389_CR90","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jnc.13399","volume":"136","author":"A Ishiki","year":"2016","unstructured":"Ishiki A, Kamada M, Kawamura Y, Terao C, Shimoda F, Tomita N, Arai H, Furukawa K (2016) Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration. J Neurochem 136:258\u2013261","journal-title":"J Neurochem"},{"key":"1389_CR91","doi-asserted-by":"publisher","unstructured":"Islam MR, Kaurani L, Berulava T, Heilbronner U, Budde M, Centeno TP, Elerdashvili V, Zafieriou MP, Benito E, Sertel SM, Goldberg M (2021) A microRNA signature that correlates with cognition and is a target against cognitive decline. EMBO Mol Med 13(11):e13659. https:\/\/doi.org\/10.15252\/emmm.202013659","DOI":"10.15252\/emmm.202013659"},{"key":"1389_CR92","doi-asserted-by":"publisher","unstructured":"Jakaria M, Belaidi AA, Bush AI, Ayton S (2021) Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease. J Neurochem 159(5):804\u2013825. https:\/\/doi.org\/10.1111\/jnc.15519","DOI":"10.1111\/jnc.15519"},{"key":"1389_CR93","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1038\/s41467-019-11762-0","volume":"10","author":"I Javed","year":"2019","unstructured":"Javed I, Peng G, Xing Y, Yu T, Zhao M, Kakinen A, Faridi A, Parish CL, Ding F, Davis TP (2019) Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy. Nat Commun 10:3780","journal-title":"Nat Commun"},{"key":"1389_CR94","doi-asserted-by":"crossref","unstructured":"Johnson EJ, Schaefer EJ (2006) Potential role of dietary n \u2013\u20093 fatty acids in the prevention of dementia and macular degeneration. Am J Clin Nutr 83:1494S\u20131498S","DOI":"10.1093\/ajcn\/83.6.1494S"},{"key":"1389_CR95","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/mp.2015.23","volume":"21","author":"G Jun","year":"2016","unstructured":"Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert J-C, Chung J, Naj AC, Kunkle BW, Wang L-S, Bis JC, Bellenguez C (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108\u2013117","journal-title":"Mol Psychiatry"},{"key":"1389_CR96","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrn.2017.36","volume":"18","author":"AW Kao","year":"2017","unstructured":"Kao AW, McKay A, Singh PP, Brunet A, Huang EJ (2017) Progranulin, lysosomal regulation and neurodegenerative disease. Nat Rev Neurosci 18:325\u2013333","journal-title":"Nat Rev Neurosci"},{"key":"1389_CR97","doi-asserted-by":"publisher","unstructured":"Kaur D, Sharma V, Deshmukh R (2019) Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer\u2019s disease. Inflammopharmacology 27:663\u2013677. https:\/\/doi.org\/10.1007\/s10787-019-00580-x","DOI":"10.1007\/s10787-019-00580-x"},{"key":"1389_CR98","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, Itzkovitz S, Colonna M, Schwartz M, Amit I (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169:1276\u20131290e1217","journal-title":"Cell"},{"key":"1389_CR99","doi-asserted-by":"publisher","unstructured":"Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C (2021) Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. Life Sci 264:118627. https:\/\/doi.org\/10.1016\/j.lfs.2020.118627","DOI":"10.1016\/j.lfs.2020.118627"},{"key":"1389_CR100","doi-asserted-by":"publisher","unstructured":"Killick R, Ribe EM, Al-Shawi R, Malik B, Hooper C, Fernandes C, Dobson R, Nolan PM, Lourdusamy AR, Furney S, Lin K (2014) Clusterin regulates \u03b2-amyloid toxicity via Dickkopf-1-driven induction of the wnt\u2013PCP\u2013JNK pathway. Mol Psychiatry 19(1):88\u201398. https:\/\/doi.org\/10.1038\/mp.2012.163","DOI":"10.1038\/mp.2012.163"},{"key":"1389_CR101","doi-asserted-by":"publisher","unstructured":"Kim KY, Shin KY, Chang KA (2023) GFAP as a Potential biomarker for Alzheimer\u2019s disease: a systematic review and meta-analysis. Cells 12:1309 https:\/\/doi.org\/10.3390\/cells12091309","DOI":"10.3390\/cells12091309"},{"key":"1389_CR102","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12035-012-8380-8","volume":"47","author":"G Kleinberger","year":"2013","unstructured":"Kleinberger G, Capell A, Haass C, Van Broeckhoven C (2013) Mechanisms of granulin deficiency: lessons from cellular and animal models. Mol Neurobiol 47:337\u2013360","journal-title":"Mol Neurobiol"},{"key":"1389_CR103","doi-asserted-by":"publisher","unstructured":"Knopman DS, Amieva H, Petersen RC (2021) Alzheimer disease. Nat Rev Dis Primers 7:33.\u00a0https:\/\/doi.org\/10.1038\/s41572-021-00269-y","DOI":"10.1038\/s41572-021-00269-y"},{"key":"1389_CR104","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1086\/316886","volume":"67","author":"LW Klomp","year":"2000","unstructured":"Klomp LW, De Koning TJ, Malingr\u00e9 HE, Van Beurden EA, Brink M, Opdam FL, Duran M, Jaeken J, Pineda M, Van Maldergem L (2000) Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency\u2014a neurometabolic disorder associated with reduced L-serine biosynthesis. Am J Hum Genet 67:1389\u20131399","journal-title":"Am J Hum Genet"},{"key":"1389_CR105","first-page":"24","volume":"4","author":"IO Korolev","year":"2014","unstructured":"Korolev IO (2014) Alzheimer\u2019s disease: a clinical and basic science review. Med Student Res J 4:24\u201333","journal-title":"Med Student Res J"},{"key":"1389_CR106","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3233\/JAD-210503","volume":"85","author":"SV Kothapalli","year":"2022","unstructured":"Kothapalli SV, Benzinger TL, Aschenbrenner AJ, Perrin RJ, Hildebolt CF, Goyal MS, Fagan AM, Raichle ME, Morris JC, Yablonskiy DA (2022) Quantitative gradient Echo MRI identifies dark matter as a new imaging biomarker of neurodegeneration that precedes tissue atrophy in early Alzheimer\u2019s Disease. J Alzheimers Dis 85:905\u2013924","journal-title":"J Alzheimers Dis"},{"key":"1389_CR107","doi-asserted-by":"publisher","unstructured":"Kowalski K, Mulak A (2019) Brain-gut-microbiota axis in Alzheimer\u2019s disease. J Neurogastroenterol Motil 25(1):48. https:\/\/doi.org\/10.5056\/jnm18087","DOI":"10.5056\/jnm18087"},{"key":"1389_CR108","doi-asserted-by":"publisher","unstructured":"Kuang J, Zhang P, Cai T, Zou Z, Li L, Wang N, Wu L (2021) Prediction of transition from mild cognitive impairment to Alzheimer's disease based on a logistic regression\u2013artificial neural network\u2013decision tree model. Geriatr Gerontol Int 21(1):43\u201347. https:\/\/doi.org\/10.1111\/ggi.14097","DOI":"10.1111\/ggi.14097"},{"key":"1389_CR109","doi-asserted-by":"publisher","unstructured":"Kumar A, Chaudhary RK, Singh R, Singh SP, Wang SY, Hoe ZY, Pan CT, Shiue YL, Wei DQ, Kaushik AC, Dai X (2020) Nanotheranostic applications for detection and targeting neurodegenerative diseases. Front Neurosci 14:305. https:\/\/doi.org\/10.3389\/fnins.2020.00305","DOI":"10.3389\/fnins.2020.00305"},{"key":"1389_CR110","doi-asserted-by":"publisher","unstructured":"Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ (2019) Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci 13:164. https:\/\/doi.org\/10.3389\/fnins.2019.00164","DOI":"10.3389\/fnins.2019.00164"},{"key":"1389_CR111","doi-asserted-by":"publisher","first-page":"e3001358","DOI":"10.1371\/journal.pbio.3001358","volume":"19","author":"V Lam","year":"2021","unstructured":"Lam V, Takechi R, Hackett MJ, Francis R, Bynevelt M, Celliers LM, Nesbit M, Mamsa S, Arfuso F, Das S (2021) Synthesis of human amyloid restricted to liver results in an Alzheimer disease\u2013like neurodegenerative phenotype. PLoS Biol 19:e3001358","journal-title":"PLoS Biol"},{"key":"1389_CR112","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/S1461145705005833","volume":"9","author":"RM Lane","year":"2006","unstructured":"Lane RM, Potkin SG, Enz A (2006) Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol 9:101\u2013124","journal-title":"Int J Neuropsychopharmacol"},{"key":"1389_CR113","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","volume":"140","author":"J Lantero Rodriguez","year":"2020","unstructured":"Lantero Rodriguez J, Karikari TK, Su\u00e1rez-Calvet M, Troakes C, King A, Emersic A, Aarsland D, Hye A, Zetterberg H, Blennow K (2020) Plasma p-tau181 accurately predicts Alzheimer\u2019s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. Acta Neuropathol 140:267\u2013278","journal-title":"Acta Neuropathol"},{"key":"1389_CR114","doi-asserted-by":"crossref","unstructured":"Lathe R, Darlix JL (2017)\u00a0Prion protein PRNP: a new player in innate immunity? The A\u03b2 connection. J Alzheimer\u2019s Dis Rep 1:263\u2013275","DOI":"10.3233\/ADR-170037"},{"key":"1389_CR115","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.cmet.2020.02.004","volume":"31","author":"J Le Douce","year":"2020","unstructured":"Le Douce J, Maugard M, Veran J, Matos M, J\u00e9go P, Vigneron P-A, Faivre E, Toussay X, Vandenberghe M, Balbastre Y (2020) Impairment of glycolysis-derived l-serine production in astrocytes contributes to cognitive deficits in Alzheimer\u2019s disease. Cell Metabol 31:503\u2013517 e508","journal-title":"Cell Metabol"},{"key":"1389_CR116","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fncel.2019.00042","volume":"13","author":"E Lee","year":"2019","unstructured":"Lee E, Chung WS (2019) Glial control of synapse number in healthy and diseased brain. Front Cell Neurosci 13:42","journal-title":"Front Cell Neurosci"},{"key":"1389_CR117","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3390\/ijms20071728","volume":"20","author":"S Lee","year":"2019","unstructured":"Lee S, Mankhong S, Kang J-H (2019) Extracellular vesicle as a source of Alzheimer\u2019s biomarkers: opportunities and challenges. Int J Mol Sci 20:1728","journal-title":"Int J Mol Sci"},{"key":"1389_CR118","doi-asserted-by":"crossref","unstructured":"Lee S-I, Jeong W, Lim H, Cho S, Lee H, Jang Y, Cho J, Bae S, Lin Y-T, Tsai L-H,\u00a0Moon DW, Seo J\u00a0(2021) APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and A\u03b2 generation. Stem Cell Rep 16:2128\u20132137","DOI":"10.1016\/j.stemcr.2021.07.017"},{"key":"1389_CR119","doi-asserted-by":"publisher","first-page":"100105","DOI":"10.1074\/jbc.REV120.008207","volume":"296","author":"P Lei","year":"2021","unstructured":"Lei P, Ayton S, Bush AI (2021) The essential elements of Alzheimer\u2019s disease. J Biol Chem 296:100105","journal-title":"J Biol Chem"},{"key":"1389_CR120","doi-asserted-by":"publisher","unstructured":"Li C, G\u00f6tz J (2017) Tau-based therapies in neurodegeneration: opportunities and challenges.\u00a0Nat Rev Drug Discov\u00a016(12):863\u2013883. https:\/\/doi.org\/10.1038\/nrd.2017.155","DOI":"10.1038\/nrd.2017.155"},{"key":"1389_CR121","doi-asserted-by":"publisher","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G (2020a) Ferroptosis: past, present and future. Cell Death Dis 11(2):88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","DOI":"10.1038\/s41419-020-2298-2"},{"key":"1389_CR122","doi-asserted-by":"publisher","unstructured":"Li H, Liu Y, Tian D, Tian L, Ju X, Qi L, Wang Y, Liang C (2020b) Overview of cannabidiol (CBD) and its analogues: structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer\u2019s disease.\u00a0Eur J Med Chem 192:112163. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112163","DOI":"10.1016\/j.ejmech.2020.112163"},{"key":"1389_CR123","doi-asserted-by":"crossref","unstructured":"Li M, Liu S, Zhu H, Guo Z, Zhi Y, Liu R, Jiang Z, Liang X, Hu H, Zhu J (2022) Decreased locus coeruleus signal associated with Alzheimer's disease based on neuromelanin-sensitive magnetic resonance imaging technique. Front Neurosci 16:1014485","DOI":"10.3389\/fnins.2022.1014485"},{"key":"1389_CR124","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","volume":"46","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Barres BA (2017) Reactive astrocytes: production, function, and therapeutic potential. Immunity 46:957\u2013967","journal-title":"Immunity"},{"key":"1389_CR125","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.bbi.2021.04.005","volume":"95","author":"Q Liu","year":"2021","unstructured":"Liu Q, Xi Y, Wang Q, Liu J, Li P, Meng X, Liu K, Chen W, Liu X, Liu Z (2021) Mannan oligosaccharide attenuates cognitive and behavioral disorders in the 5xFAD Alzheimer\u2019s disease mouse model via regulating the gut microbiota-brain axis. Brain Behav Immun 95:330\u2013343","journal-title":"Brain Behav Immun"},{"key":"1389_CR126","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fnagi.2018.00064","volume":"10","author":"JS Lopez-Noguerola","year":"2018","unstructured":"Lopez-Noguerola JS, Giessen NM, Ueber\u00fcck M, Mei\u00dfner JN, Pelgrim CE, Adams J, Wirths O, Bouter Y, Bayer TA (2018) Synergistic effect on neurodegeneration by N-Truncated A\u03b24\u2013\u200942 and pyroglutamate A\u03b23\u2013\u200942 in a mouse model of Alzheimer\u2019s disease. Front Aging Neurosci 10:64","journal-title":"Front Aging Neurosci"},{"key":"1389_CR127","doi-asserted-by":"publisher","unstructured":"Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang RF (2019) Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation 16:53. https:\/\/doi.org\/10.1186\/s12974-019-1434-3","DOI":"10.1186\/s12974-019-1434-3"},{"key":"1389_CR128","doi-asserted-by":"crossref","unstructured":"Mangalmurti A, Lukens JR (2022) How neurons die in Alzheimer's disease: implications for neuroinflammation. Curr Opin Neurobiol 75:102575","DOI":"10.1016\/j.conb.2022.102575"},{"key":"1389_CR129","doi-asserted-by":"publisher","first-page":"113224","DOI":"10.1016\/j.ejmech.2021.113224","volume":"215","author":"S Manzoor","year":"2021","unstructured":"Manzoor S, Prajapati SK, Majumdar S, Raza MK, Gabr MT, Kumar S, Pal K, Rashid H, Kumar S, Krishnamurthy S (2021) Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-alzheimer\u2019s action: design, synthesis, crystal structure and in-vitro biological evaluation. Eur J Med Chem 215:113224","journal-title":"Eur J Med Chem"},{"key":"1389_CR130","doi-asserted-by":"crossref","unstructured":"Manzoor S, Prajapati SK, Majumdar S, Khurana S, Krishnamurthy S, Hoda N (2022) Pharmacological investigations of selected multitarget-direct ligands for the treatment of Alzheimer\u2019s disease. ChemistrySelect 7:e202200975","DOI":"10.1002\/slct.202200975"},{"key":"1389_CR131","doi-asserted-by":"publisher","first-page":"616","DOI":"10.4103\/1673-5374.230276","volume":"13","author":"J Marsh","year":"2018","unstructured":"Marsh J, Alifragis P (2018) Synaptic dysfunction in Alzheimer\u2019s disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention. Neural Regeneration Res 13:616\u2013623","journal-title":"Neural Regeneration Res"},{"key":"1389_CR132","doi-asserted-by":"publisher","first-page":"108941","DOI":"10.1016\/j.abb.2021.108941","volume":"709","author":"C Mas-Bargues","year":"2021","unstructured":"Mas-Bargues C, Escriva C, Dromant M, Borras C, Vina J (2021) Lipid peroxidation as measured by chromatographic determination of malondialdehyde. Human plasma reference values in health and disease. Arch Biochem Biophys 709:108941","journal-title":"Arch Biochem Biophys"},{"key":"1389_CR133","doi-asserted-by":"publisher","unstructured":"Masaldan S, Bush AI, Devos D, Rolland AS, Moreau C (2019) Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.\u00a0Free Radic Biol Med\u00a0133:221\u2013233. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.033","DOI":"10.1016\/j.freeradbiomed.2018.09.033"},{"key":"1389_CR134","doi-asserted-by":"publisher","unstructured":"May PC, Lampert-Etchells M, Johnson SA, Poirier J, Masters JN, Finch CE (1990) Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron 5(6):831\u2013839. https:\/\/doi.org\/10.1016\/0896-6273(90)90342-d","DOI":"10.1016\/0896-6273(90)90342-d"},{"key":"1389_CR135","doi-asserted-by":"publisher","unstructured":"Mazzola C, Micale V, Drago F (2003) Amnesia induced by \u03b2-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade.\u00a0Eur J Pharmacol\u00a0477(3):219\u2013225. https:\/\/doi.org\/10.1016\/j.ejphar.2003.08.026Abstract","DOI":"10.1016\/j.ejphar.2003.08.026Abstract"},{"key":"1389_CR136","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1517\/14728222.2014.988707","volume":"19","author":"PL McGeer","year":"2015","unstructured":"McGeer PL, McGeer EG (2015) Targeting microglia for the treatment of Alzheimer\u2019s disease. Expert Opin Ther Targets 19:497\u2013506","journal-title":"Expert Opin Ther Targets"},{"key":"1389_CR137","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2017.12.003","volume":"64","author":"RK McNamara","year":"2018","unstructured":"McNamara RK, Kalt W, Shidler MD, McDonald J, Summer SS, Stein AL, Stover AN, Krikorian R (2018) Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment. Neurobiol Aging 64:147\u2013156","journal-title":"Neurobiol Aging"},{"key":"1389_CR138","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2174\/156720506779025279","volume":"3","author":"K Mi","year":"2006","unstructured":"Mi K, Johnson GV (2006) The role of tau phosphorylation in the pathogenesis of Alzheimer\u2019s disease. Curr Alzheimer Res 3:449\u2013463","journal-title":"Curr Alzheimer Res"},{"key":"1389_CR139","doi-asserted-by":"crossref","unstructured":"M\u00f6llers T, Stocker H, Perna L, Nabers A, Rujescu D, Hartmann AM, Holleczek B, Sch\u00f6ttker B, Gerwert K, Brenner H (2021) A\u03b2 misfolding in blood plasma measured by immuno-infrared\u2010sensor as an age\u2010independent risk marker of Alzheimer\u2019s disease.\u00a0Alzheimers Dement (Amst) 13:e12151","DOI":"10.1002\/dad2.12151"},{"key":"1389_CR140","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1212\/WNL.52.3.562","volume":"52","author":"T Montine","year":"1999","unstructured":"Montine T, Beal M, Cudkowicz M, O\u2019donnell H, Margolin R, McFarland L, Bachrach A, Zackert W, Roberts L, Morrow J (1999) Increased CSF F2-isoprostane concentration in probable AD. Neurology 52:562\u2013562","journal-title":"Neurology"},{"key":"1389_CR141","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fncel.2014.00112","volume":"8","author":"I Morales","year":"2014","unstructured":"Morales I, Guzm\u00e1n-Mart\u00ednez L, Cerda-Troncoso C, Far\u00edas GA, Maccioni RB (2014) Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci 8:112","journal-title":"Front Cell Neurosci"},{"key":"1389_CR142","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/brain\/awaa399","volume":"144","author":"A Moscoso","year":"2021","unstructured":"Moscoso A, Grothe MJ, Ashton NJ, Karikari TK, Rodriguez JL, Snellman A, Su\u00e1rez-Calvet M, Zetterberg H, Blennow K, Sch\u00f6ll M (2021) Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum. Brain 144:325\u2013339","journal-title":"Brain"},{"key":"1389_CR143","doi-asserted-by":"crossref","unstructured":"Nabers A, Perna L, Lange J, Mons U, Schartner J, G\u00fcldenhaupt J, Saum KU, Janelidze S, Holleczek B, Rujescu D (2018) Amyloid blood biomarker detects Alzheimer\u2019s disease. EMBO Mol Med 10:e8763","DOI":"10.15252\/emmm.201708763"},{"key":"1389_CR144","doi-asserted-by":"publisher","unstructured":"Nalawansha DA, Crews CM (2020) PROTACs: an emerging therapeutic modality in precision medicine. Cell Chemical Biol 27(8):998\u20131014. https:\/\/doi.org\/10.1016\/j.chembiol.2020.07.020","DOI":"10.1016\/j.chembiol.2020.07.020"},{"key":"1389_CR145","doi-asserted-by":"publisher","first-page":"fcab095","DOI":"10.1093\/braincomms\/fcab095","volume":"3","author":"MA Nalls","year":"2021","unstructured":"Nalls MA, Blauwendraat C, Sargent L, Vitale D, Leonard H, Iwaki H, Song Y, Bandres-Ciga S, Menden K, Faghri F, Heutink P, Cookson MR, Singleton AB (2021) Evidence for GRN connecting multiple neurodegenerative diseases. Brain Commun 3:fcab095","journal-title":"Brain Commun"},{"key":"1389_CR146","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02705243","volume":"31","author":"D Nandi","year":"2006","unstructured":"Nandi D, Tahiliani P, Kumar A, Chandu D (2006) The ubiquitin-proteasome system. J Biosci 31:137\u2013155","journal-title":"J Biosci"},{"key":"1389_CR147","doi-asserted-by":"crossref","unstructured":"Narasimhan S, Holtzman DM, Apostolova LG, Cruchaga C, Masters CL, Hardy J, Villemagne VL, Bell J, Cho M, Hampel H (2024) Apolipoprotein E in Alzheimer\u2019s disease trajectories and the next-generation clinical care pathway. Nat Neurosci\u00a027:1236\u20131252","DOI":"10.1038\/s41593-024-01669-5"},{"key":"1389_CR148","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1471-4159.2000.0750443.x","volume":"75","author":"JH Neale","year":"2000","unstructured":"Neale JH, Bzdega T, Wroblewska B (2000) N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 75:443\u2013452","journal-title":"J Neurochem"},{"key":"1389_CR149","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/bs.pbr.2015.06.015","volume":"222","author":"SF Neggers","year":"2015","unstructured":"Neggers SF, Petrov PI, Mandija S, Sommer IE, van den Berg NA (2015) Understanding the biophysical effects of transcranial magnetic stimulation on brain tissue: the bridge between brain stimulation and cognition. Prog Brain Res 222:229\u2013259","journal-title":"Prog Brain Res"},{"key":"1389_CR150","doi-asserted-by":"publisher","first-page":"112316","DOI":"10.1016\/j.envres.2021.112316","volume":"204","author":"S Nicholson","year":"2022","unstructured":"Nicholson S, Baccarelli A, Prada D (2022) Role of brain extracellular vesicles in air pollution-related cognitive impairment and neurodegeneration. Environ Res 204:112316","journal-title":"Environ Res"},{"key":"1389_CR151","doi-asserted-by":"publisher","unstructured":"Nilselid AM, Davidsson P, N\u00e4gga K, Andreasen N, Fredman P, Blennow K (2006) Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms. Neurochem Int 48(8):718\u2013728. https:\/\/doi.org\/10.1016\/j.neuint.2005.12.005","DOI":"10.1016\/j.neuint.2005.12.005"},{"key":"1389_CR152","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1038\/ncomms14727","volume":"8","author":"A Nobili","year":"2017","unstructured":"Nobili A, Latagliata EC, Viscomi MT, Cavallucci V, Cutuli D, Giacovazzo G, Krashia P, Rizzo FR, Marino R, Federici M, De Bartolo P, Aversa D, Dell\u2019Acqua MC, Cordella A, Sancandi M, Keller F, Petrosini L, Puglisi-Allegra S, Mercuri NB, Coccurello R, Berretta N, Amelio M (2017) Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease. Nat Commun 8:14727","journal-title":"Nat Commun"},{"key":"1389_CR153","doi-asserted-by":"publisher","unstructured":"Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2009) Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev 61(2):89\u2013104. https:\/\/doi.org\/10.1016\/j.brainresrev.2009.05.007","DOI":"10.1016\/j.brainresrev.2009.05.007"},{"key":"1389_CR154","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JAD-180325","volume":"67","author":"P Oeckl","year":"2019","unstructured":"Oeckl P, Halbgebauer S, Anderl-Straub S, Steinacker P, Huss AM, Neugebauer H, von Arnim CA, Diehl-Schmid J, Grimmer T, Kornhuber J (2019) Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment. J Alzheimers Dis 67:481\u2013488","journal-title":"J Alzheimers Dis"},{"key":"1389_CR155","doi-asserted-by":"publisher","first-page":"807764","DOI":"10.3389\/fnagi.2021.807764","volume":"13","author":"N Ogonowski","year":"2022","unstructured":"Ogonowski N, Salcidua S, Leon T, Chamorro-Veloso N, Valls C, Avalos C, Bisquertt A, Renter\u00eda ME, Orellana P, Duran-Aniotz C (2022) Systematic review: microRNAs as potential biomarkers in mild cognitive impairment diagnosis. Front Aging Neurosci 13:807764","journal-title":"Front Aging Neurosci"},{"key":"1389_CR156","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, \u00d6hrfelt A, Portelius E, Bjerke M, H\u00f6ltt\u00e4 M, Ros\u00e9n C, Olsson C, Strobel G (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 15:673\u2013684","journal-title":"Lancet Neurol"},{"key":"1389_CR157","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.nrl.2012.10.007","volume":"29","author":"E Orta-Salazar","year":"2014","unstructured":"Orta-Salazar E, Cuellar-Lemus CA, D\u00edaz-Cintra S, Feria-Velasco AI (2014) Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer\u2019s disease. Neurologia 29:497\u2013503","journal-title":"Neurologia"},{"key":"1389_CR158","doi-asserted-by":"publisher","unstructured":"Otsu Y, Couchman K, Lyons DG, Collot M, Agarwal A, Mallet JM, Pfrieger FW, Bergles DE, Charpak S (2015) Calcium dynamics in astrocyte processes during neurovascular coupling. Nat Neurosci 18(2):210\u2013218. https:\/\/doi.org\/10.1038\/nn.3906","DOI":"10.1038\/nn.3906"},{"key":"1389_CR159","first-page":"0","volume":"25","author":"M Padurariu","year":"2013","unstructured":"Padurariu M, Ciobica A, Lefter R, Lacramioara Serban I, Stefanescu C, Chirita R (2013) The oxidative stress hypothesis in Alzheimer\u2019s disease. Psychiatria Danubina 25:0\u2013409","journal-title":"Psychiatria Danubina"},{"key":"1389_CR160","doi-asserted-by":"publisher","unstructured":"Pagani M, Giuliani A, \u00d6berg J, Chincarini A, Morbelli S, Brugnolo A, Arnaldi D, Picco A, Bauckneht M, Buschiazzo A, Sambuceti G (2016) Predicting the transition from normal aging to Alzheimer's disease: a statistical mechanistic evaluation of FDG-PET data. Neuroimage 141:282\u2013290. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.07.043","DOI":"10.1016\/j.neuroimage.2016.07.043"},{"key":"1389_CR161","first-page":"251","volume":"11","author":"P Pandey","year":"2021","unstructured":"Pandey P, Sharma P (2021) Analysis of early onset of Alzheimer\u2019s disease genes: disease causing and risk factors. Eur J Biol Res 11:251\u2013259","journal-title":"Eur J Biol Res"},{"key":"1389_CR162","doi-asserted-by":"crossref","unstructured":"Parashar A, Mehta V, Chauhan B, Ghosh P, Deb PK, Jaiswal M, Prajapati SK (2024) Sonic Hedgehog signalling pathway contributes in age-related disorders and Alzheimer\u2019s disease. Ageing Res Rev 96:102271","DOI":"10.1016\/j.arr.2024.102271"},{"key":"1389_CR163","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3390\/cells10112903","volume":"10","author":"RM Parodi-Rull\u00e1n","year":"2021","unstructured":"Parodi-Rull\u00e1n RM, Javadov S, Fossati S (2021) Dissecting the crosstalk between endothelial mitochondrial damage, vascular inflammation, and neurodegeneration in cerebral amyloid angiopathy and Alzheimer\u2019s Disease. Cells 10:2903","journal-title":"Cells"},{"key":"1389_CR164","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JAD-180802","volume":"68","author":"G Paroni","year":"2019","unstructured":"Paroni G, Bisceglia P, Seripa D (2019) Understanding the amyloid hypothesis in Alzheimer\u2019s Disease. J Alzheimer\u2019s Disease: JAD 68:493\u2013510","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"1389_CR165","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.freeradbiomed.2018.06.038","volume":"124","author":"C Pe\u00f1a-Bautista","year":"2018","unstructured":"Pe\u00f1a-Bautista C, Vigor C, Galano J-M, Oger C, Durand T, Ferrer I, Cuevas A, L\u00f3pez-Cuevas R, Baquero M, L\u00f3pez-Nogueroles M (2018) Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection. Free Radic Biol Med 124:388\u2013394","journal-title":"Free Radic Biol Med"},{"key":"1389_CR166","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cca.2019.07.037","volume":"497","author":"C Pe\u00f1a-Bautista","year":"2019","unstructured":"Pe\u00f1a-Bautista C, Vento M, Baquero M, Chafer-Pericas C (2019) Lipid peroxidation in neurodegeneration. Clin Chim Acta 497:178\u2013188","journal-title":"Clin Chim Acta"},{"key":"1389_CR167","doi-asserted-by":"publisher","first-page":"16396","DOI":"10.1038\/s41598-020-73362-z","volume":"10","author":"C Pe\u00f1a-Bautista","year":"2020","unstructured":"Pe\u00f1a-Bautista C, Torres-Cuevas I, Baquero M, Ferrer I, Garc\u00eda L, Vento M, Ch\u00e1fer-Peric\u00e1s C (2020) Early neurotransmission impairment in non-invasive Alzheimer Disease detection. Sci Rep 10:16396","journal-title":"Sci Rep"},{"key":"1389_CR168","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2174\/1567205019666211223141524","volume":"18","author":"C Pe\u00f1a-Bautista","year":"2021","unstructured":"Pe\u00f1a-Bautista C, \u00c1lvarez-S\u00e1nchez L, Garc\u00eda L, Baquero M, Ch\u00e1fer-Peric\u00e1s C (2021) Assessment of apolipoprotein E genotype for \u03b2-amyloid status prediction. Curr Alzheimer Res 18:1032\u20131040","journal-title":"Curr Alzheimer Res"},{"key":"1389_CR169","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11033-010-0128-9","volume":"38","author":"S Peng","year":"2011","unstructured":"Peng S, Zhang Y, Zhang J, Wang H, Ren B (2011) Glutamate receptors and signal transduction in learning and memory. Mol Biol Rep 38:453\u2013460","journal-title":"Mol Biol Rep"},{"key":"1389_CR170","doi-asserted-by":"crossref","unstructured":"Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE, Zetterberg H, Stomrud E, Ashton NJ, Blennow K, Hansson O (2021) Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain\u00a0144:3505\u20133516","DOI":"10.1093\/brain\/awab223"},{"key":"1389_CR171","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13195-020-00676-5","volume":"12","author":"F Perrone","year":"2020","unstructured":"Perrone F, Bjerke M, Hens E, Sieben A, Timmers M, De Roeck A, Vandenberghe R, Sleegers K, Martin JJ, De Deyn PP, Engelborghs S, van der Zee J, Van Broeckhoven C, Cacace R (2020) Amyloid-\u03b2(1\u201343) cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations. Alzheimers Res Ther 12:108","journal-title":"Alzheimers Res Ther"},{"key":"1389_CR172","doi-asserted-by":"publisher","unstructured":"Petit D, Fern\u00e1ndez SG, Zoltowska KM, Enzlein T, Ryan NS, O\u2019Connor A, Szaruga M, Hill E, Vandenberghe R, Fox NC, Ch\u00e1vez-Guti\u00e9rrez L (2022) A\u03b2 profiles generated by Alzheimer\u2019s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset. Mol Psychiatry 27(6):2821\u20132832. https:\/\/doi.org\/10.1038\/s41380-022-01518-6","DOI":"10.1038\/s41380-022-01518-6"},{"key":"1389_CR173","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.brainres.2014.12.027","volume":"1600","author":"A Petzold","year":"2015","unstructured":"Petzold A (2015) Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease. Brain Res 1600:17\u201331","journal-title":"Brain Res"},{"key":"1389_CR174","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s43440-020-00198-9","volume":"73","author":"SK Prajapati","year":"2021","unstructured":"Prajapati SK, Krishnamurthy S (2021a) Development and treatment of cognitive inflexibility in sub-chronic stress\u2013re-stress (SRS) model of PTSD. Pharmacol Rep 73:464\u2013479","journal-title":"Pharmacol Rep"},{"key":"1389_CR175","doi-asserted-by":"publisher","first-page":"113015","DOI":"10.1016\/j.bbr.2020.113015","volume":"399","author":"SK Prajapati","year":"2021","unstructured":"Prajapati SK, Krishnamurthy S (2021b) Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: behavioural and neurochemical analyses. Behav Brain Res 399:113015","journal-title":"Behav Brain Res"},{"key":"1389_CR176","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11064-019-02944-9","volume":"45","author":"SK Prajapati","year":"2020","unstructured":"Prajapati SK, Bhaseen S, Krishnamurthy S, Sahu AN (2020) Neurochemical evidence of preclinical and clinical reports on target-based therapy in alcohol used disorder. Neurochem Res 45:491\u2013507","journal-title":"Neurochem Res"},{"key":"1389_CR177","doi-asserted-by":"crossref","unstructured":"Prajapati SK, Shah R, Alford N, Mishra SP, Jain S, Hansen B, Sanberg P, Molina AJ, Yadav H (2023) The triple alliance: microbiome, mitochondria, and metabolites in the context of age-related cognitive decline and Alzheimer\u2019s disease. J Geronto Ser A 78:2187\u20132202","DOI":"10.1093\/gerona\/glad226"},{"key":"1389_CR178","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1096\/fasebj.12.15.1777","volume":"12","author":"D Pratico","year":"1998","unstructured":"Pratico D, Lee VM-Y, Trojanowski JQ, Rokach J, Fitzgerald GA (1998) Increased F2-isoprostanes in Alzheimer\u2019s disease: evidence for enhanced lipid peroxidation in vivo. FASEB J 12:1777\u20131783","journal-title":"FASEB J"},{"key":"1389_CR179","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41380-020-0727-3","volume":"26","author":"T Pr\u00e9vot","year":"2021","unstructured":"Pr\u00e9vot T, Sibille E (2021) Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders. Mol Psychiatry 26:151\u2013167","journal-title":"Mol Psychiatry"},{"key":"1389_CR180","doi-asserted-by":"publisher","unstructured":"Rao P, Benito E, Fischer A (2013) MicroRNAs as biomarkers for CNS disease. Front Mol Neurosci 6:39. https:\/\/doi.org\/10.3389\/fnmol.2013.00039","DOI":"10.3389\/fnmol.2013.00039"},{"key":"1389_CR181","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1017\/S104161021300152X","volume":"25","author":"B Regan","year":"2013","unstructured":"Regan B, Varanelli L (2013) Adjustment, depression, and anxiety in mild cognitive impairment and early dementia: a systematic review of psychological intervention studies. Int Psychogeriatr 25:1963\u20131984","journal-title":"Int Psychogeriatr"},{"key":"1389_CR182","doi-asserted-by":"crossref","unstructured":"Rhinn H, Tatton N, McCaughey S, Kurnellas M, Rosenthal A (2022) Progranulin as a therapeutic target in neurodegenerative diseases. Trends Pharmacol Sci\u00a043:641-652","DOI":"10.1016\/j.tips.2021.11.015"},{"key":"1389_CR183","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/BF03402043","volume":"9","author":"AE Roher","year":"2003","unstructured":"Roher AE, Kuo Y-M, Esh C, Knebel C, Weiss N, Kalback W, Luehrs DC, Childress JL, Beach TG, Weller RO (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer\u2019s disease. Mol Med 9:112\u2013122","journal-title":"Mol Med"},{"key":"1389_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-01091-5","volume":"8","author":"D R\u00f6hr","year":"2020","unstructured":"R\u00f6hr D, Boon BD, Schuler M, Kremer K, Hoozemans JJ, Bouwman FH, El-Mashtoly SF, Nabers A, Gro\u00dferueschkamp F, Rozemuller AJ (2020) Label-free vibrational imaging of different A\u03b2 plaque types in Alzheimer\u2019s disease reveals sequential events in plaque development. Acta Neuropathol Commun 8:1\u201313","journal-title":"Acta Neuropathol Commun"},{"key":"1389_CR185","doi-asserted-by":"crossref","unstructured":"Ruan Y. Xiong Y, Fang W, Yu Q, Mai Y, Cao Z, Wang K, Lei M, Xu J, Liu Y, Zhang X, Liao W, Liu J (2022) Highly sensitive Curcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by magnetic resonance imaging and reversing cognitive deficits of Alzheimer's disease via NLRP3-inhibition. J Nanobiotechnology 20:322","DOI":"10.1186\/s12951-022-01524-4"},{"key":"1389_CR186","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","volume":"17","author":"M Safieh","year":"2019","unstructured":"Safieh M, Korczyn AD, Michaelson DM (2019) ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease. BMC Med 17:64","journal-title":"BMC Med"},{"key":"1389_CR187","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.4049\/jimmunol.0803612","volume":"182","author":"JM Sanz","year":"2009","unstructured":"Sanz JM, Chiozzi P, Ferrari D, Colaianna M, Idzko M, Falzoni S, Fellin R, Trabace L, Di Virgilio F (2009) Activation of microglia by amyloid {beta} requires P2X7 receptor expression. J Immunol (Baltimore Md: 1950) 182:4378\u20134385","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"1389_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00930-4","volume":"13","author":"DW Scharre","year":"2021","unstructured":"Scharre DW, Nagaraja HN, Wheeler NC, Kataki M (2021) Self-administered gerocognitive examination: longitudinal cohort testing for the early detection of dementia conversion. Alzheimers Res Ther 13:1\u201311","journal-title":"Alzheimers Res Ther"},{"key":"1389_CR189","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/JAD-2006-9S312","volume":"9","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA (2006) Alzheimer\u2019s disease-related alterations in synaptic density: neocortex and hippocampus. J Alzheimer\u2019s Disease: JAD 9:101\u2013115","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"1389_CR190","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.it.2020.02.002","volume":"41","author":"H Scheiblich","year":"2020","unstructured":"Scheiblich H, Trombly M, Ramirez A, Heneka MT (2020) Neuroimmune connections in aging and neurodegenerative diseases. Trends Immunol 41:300\u2013312","journal-title":"Trends Immunol"},{"key":"1389_CR191","doi-asserted-by":"publisher","first-page":"33747","DOI":"10.1074\/jbc.M111.246561","volume":"286","author":"H Schieb","year":"2011","unstructured":"Schieb H, Kratzin H, Jahn O, M\u00f6bius W, Rabe S, Staufenbiel M, Wiltfang J, Klafki HW (2011) \u03b2-amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic mice: comparison with human Alzheimer amyloid. J Biol Chem 286:33747\u201333758","journal-title":"J Biol Chem"},{"key":"1389_CR192","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/joim.12191","volume":"275","author":"LS Schneider","year":"2014","unstructured":"Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B (2014) Clinical trials and late-stage drug development for a lzheimer\u2019s disease: an appraisal from 1984 to 2014. J Intern Med 275:251\u2013283","journal-title":"J Intern Med"},{"key":"1389_CR193","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608","journal-title":"EMBO Mol Med"},{"key":"1389_CR194","doi-asserted-by":"publisher","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease.\u00a0Cold Spring Harb Perspect Med\u00a01(1):a006189. https:\/\/doi.org\/10.1101\/cshperspect.a006189","DOI":"10.1101\/cshperspect.a006189"},{"key":"1389_CR195","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 20:68\u201380","journal-title":"Lancet Neurol"},{"key":"1389_CR196","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ejmech.2019.02.030","volume":"167","author":"P Sharma","year":"2019","unstructured":"Sharma P, Tripathi A, Tripathi PN, Prajapati SK, Seth A, Tripathi MK, Srivastava P, Tiwari V, Krishnamurthy S, Shrivastava SK (2019) Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 167:510\u2013524","journal-title":"Eur J Med Chem"},{"key":"1389_CR197","doi-asserted-by":"publisher","first-page":"770","DOI":"10.2174\/1568026620666200228095553","volume":"20","author":"P Sharma","year":"2020","unstructured":"Sharma P, Sharma A, Fayaz F, Wakode S, Pottoo FH (2020) Biological signatures of Alzheimer\u2019s disease. Curr Top Med Chem 20:770\u2013781","journal-title":"Curr Top Med Chem"},{"key":"1389_CR198","doi-asserted-by":"publisher","first-page":"590","DOI":"10.18632\/aging.100486","volume":"4","author":"KS Sheinerman","year":"2012","unstructured":"Sheinerman KS, Tsivinsky VG, Crawford F, Mullan MJ, Abdullah L, Umansky SR (2012) Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging 4:590\u2013605","journal-title":"Aging"},{"key":"1389_CR199","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biochi.2017.12.015","volume":"147","author":"B Shui","year":"2018","unstructured":"Shui B, Tao D, Florea A, Cheng J, Zhao Q, Gu Y, Li W, Jaffrezic-Renault N, Mei Y, Guo Z (2018) Biosensors for Alzheimer\u2019s disease biomarker detection: a review. Biochimie 147:13\u201324","journal-title":"Biochimie"},{"key":"1389_CR200","doi-asserted-by":"publisher","unstructured":"Silva MC, Ferguson FM, Cai Q, Donovan KA, Nandi G, Patnaik D, Zhang T, Huang HT, Lucente DE, Dickerson BC, Mitchison TJ (2019) Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models. elife 8:e45457. https:\/\/doi.org\/10.7554\/eLife.45457","DOI":"10.7554\/eLife.45457"},{"key":"1389_CR201","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7\u201335","journal-title":"Acta Neuropathol"},{"key":"1389_CR202","doi-asserted-by":"publisher","unstructured":"Soto-Rojas LO, Pacheco-Herrero M, Mart\u00ednez-G\u00f3mez PA, Campa-C\u00f3rdoba BB, Ap\u00e1tiga-P\u00e9rez R, Villegas-Rojas MM, Harrington CR, de la Cruz F, Garc\u00e9s-Ram\u00edrez L, Luna-Mu\u00f1oz J (2021) The neurovascular unit dysfunction in Alzheimer\u2019s disease. Int J Mol Sci 22(4):2022. https:\/\/doi.org\/10.3390\/ijms22042022","DOI":"10.3390\/ijms22042022"},{"key":"1389_CR203","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00002060-195708000-00005","volume":"36","author":"WE Stone","year":"1957","unstructured":"Stone WE (1957) The role of acetylcholine in brain metabolism and function. Am J Phys Med 36:222\u2013255","journal-title":"Am J Phys Med"},{"key":"1389_CR204","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","volume":"203","author":"D Storga","year":"1996","unstructured":"Storga D, Vrecko K, Birkmayer JG, Reibnegger G (1996) Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients. Neurosci Lett 203:29\u201332","journal-title":"Neurosci Lett"},{"key":"1389_CR205","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1093\/brain\/awab154","volume":"144","author":"G Stothart","year":"2021","unstructured":"Stothart G, Smith LJ, Milton A, Coulthard E (2021) A passive and objective measure of recognition memory in Alzheimer\u2019s disease using fastball memory assessment. Brain 144:2812\u20132825","journal-title":"Brain"},{"key":"1389_CR206","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","volume":"99","author":"KH Strang","year":"2019","unstructured":"Strang KH, Golde TE, Giasson BI (2019) MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab Invest 99:912\u2013928","journal-title":"Lab Invest"},{"key":"1389_CR207","doi-asserted-by":"publisher","unstructured":"Sugiura T, Kishimoto S, Oka S, Gokoh M (2006) Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.\u00a0Prog Lipid Res\u00a045(5):405\u2013446.\u00a0https:\/\/doi.org\/10.1016\/j.plipres.2006.03.003","DOI":"10.1016\/j.plipres.2006.03.003"},{"key":"1389_CR208","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1021\/acschemneuro.7b00312","volume":"9","author":"J Sun","year":"2017","unstructured":"Sun J, Xie W, Zhu X, Xu M, Liu J (2017) Sulfur nanoparticles with novel morphologies coupled with brain-targeting peptides RVG as a new type of inhibitor against metal-induced a\u03b2 aggregation. ACS Chem Neurosci 9:749\u2013761","journal-title":"ACS Chem Neurosci"},{"key":"1389_CR209","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s13205-021-02706-x","volume":"11","author":"V Sundararajan","year":"2021","unstructured":"Sundararajan V, Venkatasubbu GD, Sheik Mohideen S (2021) Investigation of therapeutic potential of cerium oxide nanoparticles in Alzheimer\u2019s disease using transgenic Drosophila. 3 Biotech 11:159","journal-title":"3 Biotech"},{"key":"1389_CR210","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jnr.22603","volume":"89","author":"JG Sutcliffe","year":"2011","unstructured":"Sutcliffe JG, Hedlund PB, Thomas EA, Bloom FE, Hilbush BS (2011) Peripheral reduction of \u03b2-amyloid is sufficient to reduce brain \u03b2\u2010amyloid: implications for Alzheimer\u2019s disease. J Neurosci Res 89:808\u2013814","journal-title":"J Neurosci Res"},{"key":"1389_CR211","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/jnnp-2020-323520","volume":"92","author":"IJ Swift","year":"2021","unstructured":"Swift IJ, Sogorb-Esteve A, Heller C, Synofzik M, Otto M, Graff C, Galimberti D, Todd E, Heslegrave AJ, Van Der Ende EL (2021) Fluid biomarkers in frontotemporal dementia: past, present and future. J Neurol Neurosurg Psychiatry 92:204\u2013215","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1389_CR212","doi-asserted-by":"publisher","unstructured":"Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S, Ihara Y (2009) \u03b3-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of \u03b2-carboxyl terminal fragment. J Neurosci 29(41):13042\u201313052. https:\/\/doi.org\/10.1523\/JNEUROSCI.2362-09.2009","DOI":"10.1523\/JNEUROSCI.2362-09.2009"},{"key":"1389_CR213","doi-asserted-by":"publisher","first-page":"153409","DOI":"10.1016\/j.tox.2022.153409","volume":"485","author":"CKS Tekam","year":"2023","unstructured":"Tekam CKS, Majumdar S, Kumari P, Prajapati SK, Sahi AK, Shinde S, Singh R, Samaiya PK, Patnaik R, Krishnamurthy S, Mahto SK (2023) Effects of ELF-PEMF exposure on spontaneous alternation, anxiety, motor co-ordination and locomotor activity of adult Wistar rats and viability of C6 (glial) cells in culture. Toxicology 485:153409","journal-title":"Toxicology"},{"key":"1389_CR214","doi-asserted-by":"crossref","unstructured":"Thawkar BS, Kaur G (2019) Inhibitors of NF-\u03baB and P2X7\/NLRP3\/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease. J Neuroimmunol 326:62\u201374","DOI":"10.1016\/j.jneuroim.2018.11.010"},{"key":"1389_CR215","first-page":"136","volume":"34","author":"PA Thomann","year":"2009","unstructured":"Thomann PA, Kaiser E, Sch\u00f6nknecht P, Pantel J, Essig M, Schr\u00f6der J (2009) Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer disease. J Psychiatry Neurosci 34:136\u2013142","journal-title":"J Psychiatry Neurosci"},{"key":"1389_CR216","doi-asserted-by":"crossref","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A,Nair, M (2019) Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 14:5541\u20135554","DOI":"10.2147\/IJN.S200490"},{"key":"1389_CR217","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0091-3057(93)90492-C","volume":"44","author":"D Treit","year":"1993","unstructured":"Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463\u2013469","journal-title":"Pharmacol Biochem Behav"},{"key":"1389_CR218","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1006\/bbrc.1998.9382","volume":"250","author":"H-C Tseng","year":"1998","unstructured":"Tseng H-C, Graves DJ (1998) Natural methylamine osmolytes, trimethylamine N-oxide and betaine, increase tau-induced polymerization of microtubules. Biochem Biophys Res Commun 250:726\u2013730","journal-title":"Biochem Biophys Res Commun"},{"key":"1389_CR219","doi-asserted-by":"publisher","unstructured":"Valkova P, Pohanka M (2021) Novel trends in electrochemical biosensors for early diagnosis of Alzheimer\u2019s disease. Int J Anal Chem.\u00a0https:\/\/doi.org\/10.1155\/2021\/9984876","DOI":"10.1155\/2021\/9984876"},{"key":"1389_CR220","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1083\/jcb.200712039","volume":"181","author":"P Van Damme","year":"2008","unstructured":"Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, Van Swieten J, Carmeliet P, Van Den Bosch L, Robberecht W (2008) Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol 181:37\u201341","journal-title":"J Cell Biol"},{"key":"1389_CR221","doi-asserted-by":"crossref","unstructured":"Van Kampen JM, Kay DG (2017) Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer\u2019s disease. PLoS ONE 12:e0182896","DOI":"10.1371\/journal.pone.0182896"},{"key":"1389_CR222","doi-asserted-by":"publisher","unstructured":"van Oostveen WM, de Lange EC (2021) Imaging techniques in Alzheimer\u2019s disease: a review of applications in early diagnosis and longitudinal monitoring. Int J Mol Sci 22(4):2110. https:\/\/doi.org\/10.3390\/ijms22042110","DOI":"10.3390\/ijms22042110"},{"key":"1389_CR223","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.ajpath.2011.07.044","volume":"179","author":"L Vana","year":"2011","unstructured":"Vana L, Kanaan NM, Ugwu IC, Wuu J, Mufson EJ, Binder LI (2011) Progression of tau pathology in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer\u2019s disease. Am J Pathol 179:2533\u20132550","journal-title":"Am J Pathol"},{"key":"1389_CR224","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1083\/jcb.201407065","volume":"209","author":"KA Vossel","year":"2015","unstructured":"Vossel KA, Xu JC, Fomenko V, Miyamoto T, Suberbielle E, Knox JA, Ho K, Kim DH, Yu GQ, Mucke L (2015) Tau reduction prevents A\u03b2-induced axonal transport deficits by blocking activation of GSK3\u03b2. J Cell Biol 209:419\u2013433","journal-title":"J Cell Biol"},{"key":"1389_CR225","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tem.2013.10.003","volume":"25","author":"H Wang","year":"2014","unstructured":"Wang H, Eckel RH (2014) What are lipoproteins doing in the brain? Trends Endocrinol Metabolism 25:8\u201314","journal-title":"Trends Endocrinol Metabolism"},{"key":"1389_CR226","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer\u2019s Disease. J Alzheimer\u2019s Disease: JAD 57:1041\u20131048","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"1389_CR227","doi-asserted-by":"crossref","unstructured":"Wang J, Gu BJ, Masters CL, Wang Y-J (2017) A systemic view of Alzheimer disease\u2014insights from amyloid-\u03b2 metabolism beyond the brain. Nat Rev Neurol 13:612\u2013623","DOI":"10.1038\/nrneurol.2017.111"},{"key":"1389_CR228","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neulet.2018.08.016","volume":"685","author":"M Wang","year":"2018","unstructured":"Wang M, Jing T, Wang X, Yao D (2018) Beta-secretase\/BACE1 promotes APP endocytosis and processing in the endosomes and on cell membrane. Neurosci Lett 685:63\u201367","journal-title":"Neurosci Lett"},{"key":"1389_CR229","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ebiom.2019.06.021","volume":"45","author":"S Wang","year":"2019","unstructured":"Wang S, Kojima K, Mobley JA, West AB (2019) Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease. EBioMedicine 45:351\u2013361","journal-title":"EBioMedicine"},{"key":"1389_CR230","doi-asserted-by":"publisher","first-page":"9093","DOI":"10.1073\/pnas.0803072105","volume":"105","author":"GA Wayman","year":"2008","unstructured":"Wayman GA, Davare M, Ando H, Fortin D, Varlamova O, Cheng H-YM, Marks D, Obrietan K, Soderling TR, Goodman RH (2008) An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci 105:9093\u20139098","journal-title":"Proc Natl Acad Sci"},{"key":"1389_CR231","doi-asserted-by":"publisher","unstructured":"Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M (1994) Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63(3):637\u2013652. https:\/\/doi.org\/10.1016\/0306-4522(94)90511-8","DOI":"10.1016\/0306-4522(94)90511-8"},{"key":"1389_CR232","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2165\/00002512-200421070-00004","volume":"21","author":"DG Wilkinson","year":"2004","unstructured":"Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J (2004) Cholinesterase inhibitors used in the treatment of Alzheimer\u2019s disease. Drugs Aging 21:453\u2013478","journal-title":"Drugs Aging"},{"key":"1389_CR233","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/JAD-170810","volume":"61","author":"C-C Yang","year":"2018","unstructured":"Yang C-C, Chiu M-J, Chen T-F, Chang H-L, Liu B-H, Yang S-Y (2018) Assay of plasma phosphorylated tau protein (threonine 181) and total tau protein in early-stage Alzheimer\u2019s disease. J Alzheimers Dis 61:1323\u20131332","journal-title":"J Alzheimers Dis"},{"issue":"Suppl 1","key":"1389_CR234","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1471-4159.2011.07519.x","volume":"120","author":"H Zhang","year":"2012","unstructured":"Zhang H, Ma Q, Zhang YW, Xu H (2012) Proteolytic processing of Alzheimer\u2019s \u03b2-amyloid precursor protein. J Neurochem 120(Suppl 1):9\u201321","journal-title":"J Neurochem"},{"key":"1389_CR235","doi-asserted-by":"publisher","unstructured":"Zhang J, Shi L, Shen Y (2022) The retina: a window in which to view the pathogenesis of Alzheimer\u2019s disease. Ageing Res Rev 77:101590. https:\/\/doi.org\/10.1016\/j.arr.2022.101590","DOI":"10.1016\/j.arr.2022.101590"},{"key":"1389_CR236","doi-asserted-by":"publisher","unstructured":"Zheng J, Tian N, Liu F, Zhang Y, Su J, Gao Y, Deng M, Wei L, Ye J, Li H, Wang JZ (2021) A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies. Signal\u00a0Transduct Targeted Ther 6(1):269. https:\/\/doi.org\/10.1038\/s41392-021-00669-2","DOI":"10.1038\/s41392-021-00669-2"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-024-01389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-024-01389-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-024-01389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T16:32:51Z","timestamp":1724776371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-024-01389-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":236,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1007\/s11011-024-01389-6","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}